Thomas Nathaniel to Retrospective Studies
This is a "connection" page, showing publications Thomas Nathaniel has written about Retrospective Studies.
Connection Strength
1.466
-
Stroke Severity among Men and Women Acute Ischemic Stroke Patients in the Telestroke Network. Cerebrovasc Dis Extra. 2022; 12(2):93-101.
Score: 0.086
-
Retrospective analysis of comorbidities in stroke patients with a history of obstructive sleep apnea treated with thrombolytic therapy. J Vasc Nurs. 2022 06; 40(2):74-85.
Score: 0.084
-
Acute Ischemic Stroke and Heart Failure: Stroke Risk Factors Associated with Exclusion from Thrombolytic Therapy. Clin Appl Thromb Hemost. 2022 Jan-Dec; 28:10760296221116347.
Score: 0.084
-
Gender disparity in a cohort of stroke patients with incidence of obstructive sleep apnea. J Vasc Nurs. 2022 Mar; 40(1):17-27.
Score: 0.083
-
Risk factors and ambulatory outcome in ischemic stroke patients with pre-stroke depression. J Vasc Nurs. 2021 Dec; 39(4):91-99.
Score: 0.081
-
Clinical Risk Factors Associated with Ambulatory Outcome in Acute Ischemic Stroke Patient Smokers Treated with Thrombolytic Therapy. Am J Med Sci. 2021 10; 362(4):363-374.
Score: 0.080
-
Gender differences in comorbidities and risk factors in ischemic stroke patients with a history of atrial fibrillation. BMC Neurol. 2021 May 25; 21(1):209.
Score: 0.080
-
Role of dyslipidemia in ischemic stroke patients treated in the telestroke network. Adv Med Sci. 2021 Sep; 66(2):254-261.
Score: 0.080
-
Thrombolytic therapy in ischemic stroke patients with pre-stroke depression in the telestroke vs non-telestroke. J Stroke Cerebrovasc Dis. 2020 Sep; 29(9):104890.
Score: 0.075
-
Ischemic stroke with a preceding Trans ischemic attack (TIA) less than 24 hours and thrombolytic therapy. BMC Neurol. 2020 May 19; 20(1):197.
Score: 0.075
-
Cholesterol reducer and thrombolytic therapy in acute ischemic stroke patients. Lipids Health Dis. 2020 May 06; 19(1):84.
Score: 0.075
-
The Association Between an Antecedent of Transient Ischemic Attack Prior to Onset of Stroke and Functional Ambulatory Outcome. Clin Appl Thromb Hemost. 2020 Jan-Dec; 26:1076029620906867.
Score: 0.073
-
In acute ischemic stroke patients with smoking incidence, are more women than men more likely to be included or excluded from thrombolysis therapy? Womens Health (Lond). 2020 Jan-Dec; 16:1745506520922760.
Score: 0.073
-
Gender and thrombolysis therapy in acute ischemic stroke patients with incidence of obesity. Neurol Sci. 2019 Sep; 40(9):1829-1839.
Score: 0.069
-
Effect of antihypertensive medications on thrombolysis therapy and outcomes in acute ischemic stroke patients. J Clin Hypertens (Greenwich). 2019 02; 21(2):271-279.
Score: 0.068
-
Thrombolysis Therapy in Specialized and Non-specialized Stroke Units. Arch Med Res. 2018 11; 49(8):588-597.
Score: 0.068
-
Clinical Risk Factors in Thrombolysis therapy: Telestroke Versus Nontelestroke. J Stroke Cerebrovasc Dis. 2018 Sep; 27(9):2524-2533.
Score: 0.065
-
Gender Differences in Exclusion Criteria for Recombinant Tissue-Type Plasminogen Activator. J Stroke Cerebrovasc Dis. 2016 Nov; 25(11):2569-2574.
Score: 0.058
-
Co-morbid conditions in use of recombinant tissue plasminogen activator (rt-PA) for the treatment of acute ischaemic stroke. Brain Inj. 2016; 30(10):1261-5.
Score: 0.057
-
Tissue plasminogen activator (rt-PA) in acute ischemic stroke: Outcomes associated with ambulation. Restor Neurol Neurosci. 2015; 33(3):301-8.
Score: 0.051